Reduction of Leukocyte Microvascular Adherence and Preservation of Blood-Brain Barrier Function by Superoxide-Lowering Therapies in a Piglet Model of Neonatal Asphyxia
Background: Asphyxia is the most common cause of brain damage in newborns. Substantial evidence indicates that leukocyte recruitment in the cerebral vasculature during asphyxia contributes to this damage. We tested the hypothesis that superoxide radical (O2⋅_) promotes an acute post-asphyxial inflam...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2019.00447/full |
id |
doaj-10df08ffead34f4eb3cfb11b99717d32 |
---|---|
record_format |
Article |
spelling |
doaj-10df08ffead34f4eb3cfb11b99717d322020-11-25T02:27:42ZengFrontiers Media S.A.Frontiers in Neurology1664-22952019-05-011010.3389/fneur.2019.00447450892Reduction of Leukocyte Microvascular Adherence and Preservation of Blood-Brain Barrier Function by Superoxide-Lowering Therapies in a Piglet Model of Neonatal AsphyxiaJacob B. Ruden0Kevin L. Quick1Ernesto R. Gonzales2Aarti R. Shah3Aarti R. Shah4T. S. Park5Nan Kennedy6Laura L. Dugan7Laura L. Dugan8Jeffrey M. Gidday9Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN, United StatesPerkinElmer, Waltham, MA, United StatesHope Center for Neurological Disorders and Department of Neurology, Washington University in Saint Louis School of Medicine, St. Louis, MO, United StatesHope Center for Neurological Disorders and Department of Neurology, Washington University in Saint Louis School of Medicine, St. Louis, MO, United StatesKnight Alzheimer's Disease Research Center, Washington University in Saint Louis School of Medicine, St. Louis, MO, United StatesDepartment of Neurosurgery, St. Louis Children's Hospital, Washington University in Saint Louis School of Medicine, St. Louis, MO, United StatesVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, United StatesVanderbilt Brain Institute, Vanderbilt University, Nashville, TN, United StatesDivision of Geriatric Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United StatesDepartments of Ophthalmology, Physiology, and Neuroscience, Louisiana State University School of Medicine, New Orleans, LA, United StatesBackground: Asphyxia is the most common cause of brain damage in newborns. Substantial evidence indicates that leukocyte recruitment in the cerebral vasculature during asphyxia contributes to this damage. We tested the hypothesis that superoxide radical (O2⋅_) promotes an acute post-asphyxial inflammatory response and blood-brain barrier (BBB) breakdown. We investigated the effects of removing O2⋅_ by superoxide dismutase (SOD) or C3, the cell-permeable SOD mimetic, in protecting against asphyxia-related leukocyte recruitment. We also tested the hypothesis that xanthine oxidase activity is one source of this radical.Methods: Anesthetized piglets were tracheostomized, ventilated, and equipped with closed cranial windows for the assessment of post-asphyxial rhodamine 6G-labeled leukocyte-endothelial adherence and microvascular permeability to sodium fluorescein in cortical venules. Asphyxia was induced by discontinuing ventilation. SOD and C3 were administered by cortical superfusion. The xanthine oxidase inhibitor oxypurinol was administered intravenously.Results: Leukocyte-venular adherence significantly increased during the initial 2 h of post-asphyxial reperfusion. BBB permeability was also elevated relative to non-asphyxial controls. Inhibition of O2⋅_ production by oxypurinol, or elimination of O2⋅_ by SOD or C3, significantly reduced rhodamine 6G-labeled leukocyte-endothelial adherence and improved BBB integrity, as measured by sodium fluorescein leak from cerebral microvessels.Conclusion: Using three different strategies to either prevent formation or enhance elimination of O2⋅_ during the post-asphyxial period, we saw both reduced leukocyte adherence and preserved BBB function with treatment. These findings suggest that agents which lower O2⋅_ in brain may be attractive new therapeutic interventions for the protection of the neonatal brain following asphyxia.https://www.frontiersin.org/article/10.3389/fneur.2019.00447/fullasphyxiacarboxyfullereneendotheliuminflammationleukocytesoxypurinol |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jacob B. Ruden Kevin L. Quick Ernesto R. Gonzales Aarti R. Shah Aarti R. Shah T. S. Park Nan Kennedy Laura L. Dugan Laura L. Dugan Jeffrey M. Gidday |
spellingShingle |
Jacob B. Ruden Kevin L. Quick Ernesto R. Gonzales Aarti R. Shah Aarti R. Shah T. S. Park Nan Kennedy Laura L. Dugan Laura L. Dugan Jeffrey M. Gidday Reduction of Leukocyte Microvascular Adherence and Preservation of Blood-Brain Barrier Function by Superoxide-Lowering Therapies in a Piglet Model of Neonatal Asphyxia Frontiers in Neurology asphyxia carboxyfullerene endothelium inflammation leukocytes oxypurinol |
author_facet |
Jacob B. Ruden Kevin L. Quick Ernesto R. Gonzales Aarti R. Shah Aarti R. Shah T. S. Park Nan Kennedy Laura L. Dugan Laura L. Dugan Jeffrey M. Gidday |
author_sort |
Jacob B. Ruden |
title |
Reduction of Leukocyte Microvascular Adherence and Preservation of Blood-Brain Barrier Function by Superoxide-Lowering Therapies in a Piglet Model of Neonatal Asphyxia |
title_short |
Reduction of Leukocyte Microvascular Adherence and Preservation of Blood-Brain Barrier Function by Superoxide-Lowering Therapies in a Piglet Model of Neonatal Asphyxia |
title_full |
Reduction of Leukocyte Microvascular Adherence and Preservation of Blood-Brain Barrier Function by Superoxide-Lowering Therapies in a Piglet Model of Neonatal Asphyxia |
title_fullStr |
Reduction of Leukocyte Microvascular Adherence and Preservation of Blood-Brain Barrier Function by Superoxide-Lowering Therapies in a Piglet Model of Neonatal Asphyxia |
title_full_unstemmed |
Reduction of Leukocyte Microvascular Adherence and Preservation of Blood-Brain Barrier Function by Superoxide-Lowering Therapies in a Piglet Model of Neonatal Asphyxia |
title_sort |
reduction of leukocyte microvascular adherence and preservation of blood-brain barrier function by superoxide-lowering therapies in a piglet model of neonatal asphyxia |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Neurology |
issn |
1664-2295 |
publishDate |
2019-05-01 |
description |
Background: Asphyxia is the most common cause of brain damage in newborns. Substantial evidence indicates that leukocyte recruitment in the cerebral vasculature during asphyxia contributes to this damage. We tested the hypothesis that superoxide radical (O2⋅_) promotes an acute post-asphyxial inflammatory response and blood-brain barrier (BBB) breakdown. We investigated the effects of removing O2⋅_ by superoxide dismutase (SOD) or C3, the cell-permeable SOD mimetic, in protecting against asphyxia-related leukocyte recruitment. We also tested the hypothesis that xanthine oxidase activity is one source of this radical.Methods: Anesthetized piglets were tracheostomized, ventilated, and equipped with closed cranial windows for the assessment of post-asphyxial rhodamine 6G-labeled leukocyte-endothelial adherence and microvascular permeability to sodium fluorescein in cortical venules. Asphyxia was induced by discontinuing ventilation. SOD and C3 were administered by cortical superfusion. The xanthine oxidase inhibitor oxypurinol was administered intravenously.Results: Leukocyte-venular adherence significantly increased during the initial 2 h of post-asphyxial reperfusion. BBB permeability was also elevated relative to non-asphyxial controls. Inhibition of O2⋅_ production by oxypurinol, or elimination of O2⋅_ by SOD or C3, significantly reduced rhodamine 6G-labeled leukocyte-endothelial adherence and improved BBB integrity, as measured by sodium fluorescein leak from cerebral microvessels.Conclusion: Using three different strategies to either prevent formation or enhance elimination of O2⋅_ during the post-asphyxial period, we saw both reduced leukocyte adherence and preserved BBB function with treatment. These findings suggest that agents which lower O2⋅_ in brain may be attractive new therapeutic interventions for the protection of the neonatal brain following asphyxia. |
topic |
asphyxia carboxyfullerene endothelium inflammation leukocytes oxypurinol |
url |
https://www.frontiersin.org/article/10.3389/fneur.2019.00447/full |
work_keys_str_mv |
AT jacobbruden reductionofleukocytemicrovascularadherenceandpreservationofbloodbrainbarrierfunctionbysuperoxideloweringtherapiesinapigletmodelofneonatalasphyxia AT kevinlquick reductionofleukocytemicrovascularadherenceandpreservationofbloodbrainbarrierfunctionbysuperoxideloweringtherapiesinapigletmodelofneonatalasphyxia AT ernestorgonzales reductionofleukocytemicrovascularadherenceandpreservationofbloodbrainbarrierfunctionbysuperoxideloweringtherapiesinapigletmodelofneonatalasphyxia AT aartirshah reductionofleukocytemicrovascularadherenceandpreservationofbloodbrainbarrierfunctionbysuperoxideloweringtherapiesinapigletmodelofneonatalasphyxia AT aartirshah reductionofleukocytemicrovascularadherenceandpreservationofbloodbrainbarrierfunctionbysuperoxideloweringtherapiesinapigletmodelofneonatalasphyxia AT tspark reductionofleukocytemicrovascularadherenceandpreservationofbloodbrainbarrierfunctionbysuperoxideloweringtherapiesinapigletmodelofneonatalasphyxia AT nankennedy reductionofleukocytemicrovascularadherenceandpreservationofbloodbrainbarrierfunctionbysuperoxideloweringtherapiesinapigletmodelofneonatalasphyxia AT lauraldugan reductionofleukocytemicrovascularadherenceandpreservationofbloodbrainbarrierfunctionbysuperoxideloweringtherapiesinapigletmodelofneonatalasphyxia AT lauraldugan reductionofleukocytemicrovascularadherenceandpreservationofbloodbrainbarrierfunctionbysuperoxideloweringtherapiesinapigletmodelofneonatalasphyxia AT jeffreymgidday reductionofleukocytemicrovascularadherenceandpreservationofbloodbrainbarrierfunctionbysuperoxideloweringtherapiesinapigletmodelofneonatalasphyxia |
_version_ |
1724841271833395200 |